Jennifer Champoux
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $311K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 16SEC | GLUEMonte Rosa Therapeutics, Inc. | Sell Plan | 4,35162,371 held (−7%) | $23.38 | $102K | -55.9% |
| Jun 25SEC | GLUEMonte Rosa Therapeutics, Inc. | Sell Plan | 2,17562,371 held (−3%) | $20.00 | $44K | -48.5% |
| Jun 18SEC | GLUEMonte Rosa Therapeutics, Inc. | Sell Plan | 2,17662,371 held (−3%) | $19.00 | $41K | -45.8% |
| May 28SEC | GLUEMonte Rosa Therapeutics, Inc. | Sell Plan | 2,17562,371 held (−3%) | $20.00 | $44K | -48.5% |
| May 26SEC | GLUEMonte Rosa Therapeutics, Inc. | Sell Plan | 2,17662,371 held (−3%) | $19.00 | $41K | -45.8% |
| Jan 5SEC | GLUEMonte Rosa Therapeutics, Inc. | Sell | 2,62962,371 held (−4%) | $15.17 | $40K | -32.1% |
- Sell
COO Jennifer Champoux sold $102K of GLUE at $23.38 — pre-scheduled 10b5-1 plan sale.
- Sell
COO Jennifer Champoux sold $44K of GLUE at $20.00 — pre-scheduled 10b5-1 plan sale.
- Sell
COO Jennifer Champoux sold $41K of GLUE at $19.00 — pre-scheduled 10b5-1 plan sale.
- Sell
COO Jennifer Champoux sold $44K of GLUE at $20.00 — pre-scheduled 10b5-1 plan sale.
- Sell
COO Jennifer Champoux sold $41K of GLUE at $19.00 — pre-scheduled 10b5-1 plan sale.